三维超声测量正常中晚期单胎妊娠胎儿产尿率

目的 应用三维超声测量正常中晚期单胎妊娠胎儿的膀胱容量以估算不同孕期胎儿的产尿率,并探讨胎儿产尿率与孕周及羊水指数之间的关系.方法 对138例正常中晚期单胎妊娠胎儿进行三维超声检查,采用三维超声体积自动测量技术,间隔5～15 min,重复2～3次测量胎儿膀胱容量并计算产尿率.结果 胎儿的产尿率随孕周增加而增加,自孕24周的12.84 ml/h升至孕42周的64.70 ml/h,二者之间有明显相关关系(r=0.900,P<0.05).胎儿的产尿率与羊水指数无明显相关关系(r=-0.199,P>0.05).结论 运用三维超声体积自动测量技术测量正常中晚期单胎妊娠胎儿的膀胱容量变化可估算胎儿的产尿率,并可了解胎儿肾功能状态及宫内安危情况.     

三维超声检测先天性心脏病胎儿的产尿率

目的尝试建立国人胎儿产尿率(UPR)的正常值,并以此评估先天性心脏病(CHD)胎儿的UPR改变情况。方法选择连续检测的49胎CHD胎儿作为病例组,将其分为左心梗阻性病变组、右心梗阻性病变组和混合心脏畸形组;根据胎儿CHD有无合并充血性心力衰竭(CHF)再分为合并CHF组和未合并CHF组。选取同期正常21～40孕(GA)周单胎妊娠胎儿314胎作为正常对照组。采用三维超声体积自动测量(VOCAL)技术测量各组胎儿UPR并进行比较。结果①胎儿UPR随GA增大而增加(r2=0.92,P<0.05),相关方程为:ln(UPR)=-4.7480+(0.3975×GA)+(-0.0044×GA2);②胎儿UPR的改变与胎儿有无CHD及其CHD类型无关(P>0.05);③胎儿UPR与胎儿CHD的心脏功能有关,CHD胎儿合并CHF时UPR下降(P<0.01)。结论 UPR可能是判断胎儿心力衰竭的一项有价值的指标。     

Three-dimensional sonographic assessment of fetal urine production before and after laser surgery in twin-to-twin transfusion syndrome.

OBJECTIVE: Fetal urine production in twin-to-twin transfusion syndrome (TTTS) reflects the hemodynamic imbalance between the donor and recipient twins but it has not been measured in this particular condition. The aim of this study was to measure fetal urine production using three-dimensional (3D) ultrasound in donor and recipient twins before and after laser treatment for TTTS and to correlate this with umbilical venous volume flow (UVVF). METHODS: Urine production rate (UPR) was measured using 3D ultrasound with Virtual Organ Computer-aided AnaLysis (VOCAL) in 106 cases of severe TTTS. The rotation angle was set at 30 degrees . The bladder volume was measured twice in each fetus (V(1) and V(2)), with an interval of 5-30 min between measurements, in order to calculate the UPR. When V(2) > V(1), UPR was calculated using the formula: V(2) - V(1) /time interval. Together with UPR, UVVF was measured before and after treatment. Both parameters were corrected for fetal weight. Inter- and intraobserver variability were calculated in 16 cases using the intraclass correlation coefficient. RESULTS: Before laser treatment, UPR was significantly higher in recipients compared with donors (median, 14.8 and 0 mL/h/kg, mean 23.8 and 2.3 mL/h/kg, respectively, P < 0.001), and UPR was positively correlated with UVVF in both twins. Following laser treatment (48 h later), UPR decreased to 9 mL/h/kg (P < 0.001) in recipients, while there was no change in donors. UVVF increased significantly from a median value of 92 to 132 mL/min/kg (P < 0.01) in donors and decreased significantly from 150 to 99 mL/min/kg (P < 0.001) in recipients. CONCLUSIONS: In TTTS UPR is correlated to UVVF and reflects the hemodynamic imbalance between donor and recipient twins. Following laser treatment, UPR decreases in recipients but is unaffected in donors. However, changes in UVVF occur in both twins. This suggests that although fetal renal function is driven by fetal hemodynamics, there may be a lag in the recovery of renal function in the donor twin.     

Fetal clavicle length throughout gestation: a nomogram.

OBJECTIVE: To create a nomogram of fetal clavicle length (CL) throughout gestation. METHODS: Cross-sectional study of patients between 14 and 42 weeks' gestation. Inclusion criteria consisted of well-established dates (consistent with early ultrasound), singleton, non-anomalous fetuses, and intact amniotic membranes. Sonographic measurements included biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL), humerus length (HL) and sonographically estimated fetal weight (SEFW). For every case, the average of three separate measurements of the CL was used. The 5th, 50th and 95th centiles were obtained by least squares regression. Pearson's correlation coefficient and associated P-values for the relationships between CL and other biometric measurements were calculated. The data were compared to a nomogram of the CL generated in 1985 from the measurement of 85 fetuses. RESULTS: A total of 623 consecutive patients were studied. In all but three cases, CL was successfully measured. Mean maternal age was 27.7 +/- 6.2 years, median gravidity 3 (range, 1-14) and median parity 1 (range, 0-9). Mean CL (mm) = -75.30 + 32.70*ln(GA) and SD = -0.41 + 0.08328*GA, where ln represents the natural logarithm and GA the gestational age in weeks. Fetal CL correlated significantly and strongly with BPD, HC, AC, HL, FL and the logarithm of SEFW, with Pearson correlation values of 0.973, 0.977, 0.976, 0.979, 0.977 and 0.979, respectively (all P < 0.001). Measurements according to comparable 1985 data were consistently substantially below the present data (smaller CL for any given GA except below 17 weeks' gestation). CONCLUSIONS: We propose a new nomogram of CL, which differs significantly from the previously published nomogram. We suggest that the present data reflect the use of high-resolution ultrasound technology and propose that these data, based on a large number of fetuses, replace the previous nomogram. We also suggest that the '1 mm = 1 week' rule of thumb should no longer be used, since it can be erroneous by as much as 6 weeks.     

Assessment of the third-trimester fetus using 3-dimensional volumes: a pilot study

PURPOSE: To examine whether the third-trimester fetus can be assessed sonographically using 3-dimensional (3D) volume data sets. METHODS: Twenty-seven consecutive third-trimester fetuses were evaluated. Fetuses were scanned using 2-dimensional (2D) imaging followed by 5 3D volume acquisitions. The initial scan was interpreted and reported based on the 2D images. The 3D volume data sets were independently reviewed offline several weeks later by 2 sonologists. Parameters evaluated included fetal presentation, placental location, amniotic fluid volume, fetal biometry including a calculation of estimated fetal weight, and major fetal anatomic structures. The result of the interpretation via 3D reconstruction of the volume from each of the 2 sonologists was compared with the original 2D sonography report. RESULTS: Fetal presentation, amniotic fluid volume, and placental location with respect to the cervix were correctly identified 100% of the time by each sonologist. The estimated fetal weight was within 10% of the 2D estimate 89% (95% CI, 0.71-0.98) of the time for sonologist A and 96% (95% CI, 0.81-0.99) of the time for sonologist B. The majority of major anatomic landmarks were adequately seen by both sonologists. CONCLUSION: Offline review of 3D volume data sets is a reliable method for determining fetal presentation, amniotic fluid volume, placental location, and estimating fetal weight in the third trimester.     

Correlation between fetal gastric size and amniotic fluid volume

PURPOSE: Since abnormal conditions of the fetal digestive tract may alter both amniotic fluid volume and fetal gastric volume, we sought to determine whether amniotic fluid volume is correlated with fetal gastric volume in normal pregnancy. METHODS: A total of 280 fetal gastric size measurements were made prospectively from routine sonographic examinations of women with normal singleton pregnancies between 16 and 42 weeks of gestation. The fetal stomach was defined as the largest area including the pyloric site on transverse or oblique real-time sonographic scans. Gastric volume was calculated according to the formula for a prolate ellipsoid. The amniotic fluid index (AFI) was used for the evaluation of amniotic fluid volume. RESULTS: Both fetal gastric volume and AFI were significantly correlated with gestational age (R2= 0.422 and R2= 0.128, respectively). Only a weak correlation was found between gastric volume and AFI (R2= 0.036, p <0.001). On multivariate linear regression analysis adjusting for gestational age and fetal biometric measurements, gastric volume was not an independent and significant predictor of AFI. CONCLUSIONS: Although sonographically determined fetal gastric volume measurements appear to be useful in the assessment of fetal digestive tract anomalies, fetal gastric volume has no clinically significant effect on the amniotic fluid volume in normal pregnancy.     

Nomograms of sonographic measurements throughout gestation of the fetal hard palate width, length and area.

OBJECTIVE: To assess the feasibility of sonographic depiction of the fetal hard palate and secondarily to create nomograms throughout gestation of its sonographic width, length and area. METHODS: This was a cross-sectional study of pregnant patients between 15 and 41 weeks' gestation. Inclusion criteria consisted of well-established dates (confirmed by early ultrasound), and singleton, non-anomalous fetuses. Sonographic measurements obtained included biparietal diameter, head circumference, abdominal circumference and femur length. Fetal hard palate measurements included maximum width, maximum length and the calculated area. Tables were prepared depicting the estimated mean +/- SD and 5(th), 50(th) and 95(th) centiles at each gestational week between 15 and 41 weeks. Pearson's correlation coefficient and associated P-values for the relationships between fetal hard palate measurements and other sonographic measurements and coefficients of variation for each of the fetal hard palate measurements were calculated. RESULTS: The study included 602 consecutive patients. The mean maternal age was 28.7 +/- 6.3 years, with median gravidity of 2 (range, 1-12) and parity 1 (range, 0-8). All attempts at obtaining fetal hard palate ultrasound measurements were successful. Mean fetal hard palate width (cm) = -0.73579345 + 0.11370432 x GA - 0.00083919 x GA(2) and SD = -0.017842055 + 0.005142475 x GA, where GA is gestational age in weeks. Mean fetal hard palate length (cm) = -0.82020463 + 0.11767777 x GA - 0.00092801 x GA(2) and SD = -0.043064317 + 0.006378869 x GA. Mean fetal hard palate area (cm(2)) = -2.40090641 + 0.17136556 x GA + 0.00097308 x GA(2) and SD = -0.603647741 + 0.040740282 x GA. Sonographic measurements of the fetal hard palate width, length and area correlated significantly and strongly with gestational age (all P < 0.001) and significantly but less strongly with femur length (P = 0.004). CONCLUSION: The fetal hard palate may be depicted sonographically with relative ease between 15 and 41 weeks' gestation and measurements of the fetal hard palate width, length and area correlate well with gestational age, biparietal diameter, abdominal circumference, sonographic estimated fetal weight, and femur length.     

Is there a relationship between fetal weight and amniotic fluid index?

OBJECTIVE: To establish whether there is a relationship between the amniotic fluid index and estimated fetal weight in the third trimester. The presence of a relationship would require adjustment of amniotic fluid index to take account of estimated fetal weight with potential improvement in its prediction of adverse perinatal outcomes. METHODS: Paired measurements of amniotic fluid index and estimated fetal weight from 274 low-risk pregnancies enrolled in a longitudinal study of fetal growth. Measurements were made at fortnightly intervals from 30 weeks' gestation until delivery. A relationship between amniotic fluid index and estimated fetal weight was sought at gestational age week intervals of 30-32, 33-35, 36-38 and 39-41. RESULTS: One thousand and three pairs of measurements of amniotic fluid index and estimated fetal weight were available for analysis. Mean amniotic fluid index decreased towards term as expected. There was no correlation between amniotic fluid index and estimated fetal weight. Furthermore, there was no correlation between amniotic fluid index and estimated fetal weight at any of the gestational age intervals. CONCLUSIONS: There is no clinically relevant correlation between amniotic fluid index and estimated fetal weight. It should remain clinical practice to take account of gestational age when interpreting amniotic fluid index but it is not necessary to make adjustments for estimated fetal weight.     

Tobramycin: Maternal-Fetal Pharmacology

To investigate the maternal-fetal transfer of tobramycin (TBM) and its distribution in the fetus, a single dose of 2 mg/kg was administered intramuscularly to 35 pregnant patients (13 first trimester, 22 second trimester) 0.5 to 34 h before hysterectomy. TBM concentration was assayed microbiologically in maternal serum, fetal tissues (placenta, brain, lung, liver, and kidney), and fluids (amniotic, cerebrospinal fluid [CSF], urine, and serum). Mean maternal serum half-life (1.54 h) and mean peak serum concentration of TBM were within ranges reported for nonpregnant adults. In fetal serum, half-life was 5.2 h, and TBM levels did not exceed 0.58 μg/ml. For intervals up to 34 h, the mean TBM concentration in placental tissues was 1.4 μg/g. Concentration differences related to fetal maturation were found for fetal CSF, amniotic fluid, and fetal kidney. No antimicrobial activity was found in the fetal CSF of >16 weeks' gestation. TBM was present predominantly in the second trimester amniotic fluid specimens. Fetal kidney concentrations reached 7.2 μg/g at 34 h after maternal drug administration. Higher TBM concentrations were related to advanced maturation of the fetal kidney. Second trimester fetal urine concentrations for TBM ranged from 0.1 to 3.4 μg/ml, and the fetal urinary half-life was 3.7 h. Knowledge of fetal pharmacology is essential for weighing the fetal benefits or risks of antimicrobial therapy for the infected gravid patient.     

Subjective versus objective evaluation of amniotic fluid volume of pregnancies of less than 24 weeks' gestation: how can we be accurate?

This study was undertaken to compare subjective versus objective ultrasonic evaluation of amniotic fluid volume in pregnancies of less than 24 weeks' gestation. Amniotic fluid volume was subjectively (visualization without ultrasonic measurements) and objectively (visual interpretation with ultrasonic measurements) evaluated in 42 singleton pregnancies undergoing termination. The actual amniotic fluid volume was then determined using a dye-dilution technique. The women evaluated were in their mid-20s, primarily African American, and between 15 and 23 weeks' gestation. There was no significant difference in the total number of correct estimates of amniotic fluid volume when the data were stratified by level of operator experience (P = .34), ultrasonic technique (P = .33), or the combined correct subjective versus combined correct objective estimates (P = .68). We have concluded that the accuracy of amniotic fluid volume assessment in pregnancies of less than 24 weeks is not influenced by the level of operator experience or the type of ultrasonic measurement.     

High perinatal survival in monoamniotic twins managed by prophylactic sulindac, intensive ultrasound surveillance, and Cesarean delivery at 32 weeks' gestation.

OBJECTIVES: Increased perinatal mortality in monoamniotic twin pregnancies is attributed to cord accidents in utero and at delivery. We evaluated the following parameters in monoamniotic pregnancies: (1) the incidence of cord entanglement; (2) the effect of sulindac on amniotic fluid volume and stability of fetal lie; and (3) the perinatal outcome with our current management paradigm. METHODS: This is a retrospective review of monoamniotic pregnancies of >or=20 weeks' gestation managed with serial ultrasound surveillance, medical amnioreduction and elective Cesarean delivery at 32 weeks' gestation. Mean amniotic fluid index (AFI) and change in AFI in monoamniotic pregnancies managed with oral sulindac was compared with 40 gestation-matched monochorionic-diamniotic controls. RESULTS: Among 44 monoamniotic pregnancies, 20 with two live structurally normal twins at 20 weeks' gestation satisfied the inclusion criteria. All fetuses survived to 28 days postnatally despite early prenatal cord entanglement in all but one case. Whereas AFI remained stable throughout gestation in the controls, the AFI fell in those patients on sulindac from a mean value of 21.0 cm (95% CI, 18.5-23.6 cm) at 20 weeks to a mean of 12.4 cm (95% CI, 10.1-14.6 cm) at 32 weeks (ANOVA P across gestation = 0.001) but mainly remained within normal limits. Fetal lie was stabilized in 11/20 cases in the monoamniotic group compared with 13/40 in the control group (P < 0.0001). CONCLUSIONS: Cord entanglement appears unpreventable, as it typically occurs in early pregnancy. Sulindac therapy reduces AFI, leads to more stable fetal lie, and may prevent intrauterine death by diminishing the risk of constricting cords that are already entangled. Perinatal survival in monoamniotic pregnancies managed by a regime of sulindac from 20 weeks' gestation, close ultrasound surveillance and elective abdominal delivery at 32 weeks' gestation seems empirically higher than that in the literature.     

Fetal urine production and accuracy when estimating fetal urinary bladder volume.

OBJECTIVES: The volume of the fetal urinary bladder can be estimated by measuring bladder diameters on an ultrasound image. The calculated urine production rate might reflect the fetal status in compromised pregnancies. The aim of this study was to assess the fetal urine production rate and the accuracy of measurements of diameters and volumes of the bladder. DESIGN: Urine production rate and the variability in volume measurement error were assessed by ultrasound examinations of fetal bladder images documented on videotapes. In material comprising 101 longitudinal and 90 transverse bladder images, the variability (SD) in distance measurement error was estimated for the bladder diameters. Using this SD, the variability in volume measurement error in the selected bladder image was also calculated. RESULTS: The urine production rate for fetuses of 20, 25, 30, 35 and 40 weeks is 4.2, 12.1, 22.7, 36.1 and 52.2 mL/h, respectively. The SD for volume measurement error when selecting bladder images with a volume of 5, 10, 20, 30 and 40 mL is 17.3%, 13.6%, 11.8%, 11.2% and 10.9% of the actual volume, respectively. The corresponding SD when measuring the volume of selected bladder images accounted for 3.7-2.0%. CONCLUSIONS: The urine production rate presented here is in parity with recent previous reports. We distinguish between different kinds of measurement error. The variability was mostly related to the selection of appropriate bladder image, whereas measurement of the selected bladder image accounted for only a minor part of the resulting variability.     

Effect of maternal hydration on mild fetal pyelectasis.

The aim of our study was to determine whether maternal hydration status prior to prenatal sonography affects fetal renal pelvic diameter. The renal pelvic diameters of fetuses from two different institutions were compared prospectively. At one institution 74 women were asked to drink 32 to 48 ounces of water prior to undergoing sonography (hydration group), whereas at the second institution, no specific hydration regimen was requested of 176 subjects. The inclusion criteria were as follows: greater than 15 weeks' gestation, otherwise normal obstetrical sonogram, normal amniotic fluid volume, and negative family history for renal disease. Renal pelvic diameter, degree of maternal bladder fullness, and gestational age were compared between the two groups using logistic regression analysis and log-linear analysis. A P value < 0.01 was considered significant. Bladder fullness in the two groups differed significantly (P < 0.001). Logistic regression analysis showed a very strong effect of maternal bladder fullness on fetal renal pelvic diameter (P < 0.001). The log-linear analysis model showed a highly significant association between maternal bladder fullness and fetal renal pelvic diameter (P < 0.001). We conclude that maternal hydration influences fetal renal pelvic diameter. The larger fetal renal diameters seen in the hydrated group support physiologic theories that the effects of maternal hydration on amniotic fluid volume are partially mediated via fetal urine production.     

Prenatal diagnosis of ranula at 21 weeks of gestation.

A fetal sublingual cystic lesion was diagnosed by routine prenatal ultrasonography at 21 weeks of gestation and followed up until term in a tertiary care center. Fetal growth was normal as was the amniotic fluid volume. Ex utero intrapartum treatment was performed and the cyst was aspirated to allow breathing and swallowing during planned Cesarean section. The cyst was totally excised when the newborn was 27 days of age and histological examination revealed a mucous cyst of the mouth floor.     

Nomogram of the fetal alveolar ridge: a possible screening tool for the detection of primary cleft palate.

OBJECTIVE: The objective of this study was to obtain a nomogram of the fetal alveolar ridge development, as a basis for the diagnosis of primary cleft palate. DESIGN: A cross-sectional study of 323 normal pregnant women of 14-32 weeks' gestation. Several biometric measurements were obtained throughout pregnancy, including the width of the fetal alveolar ridge. RESULTS: A nomogram of the width of the fetal alveolar ridge during 14-32 weeks' gestation is presented. A linear growth function was observed between alveolar ridge width and gestational age, biparietal diameter, head circumference, femoral length and humeral length. The alveolar ridge width in all eight cases of cleft palate was above two standard deviations and the 90th centile of our nomogram. CONCLUSION: We provide a nomogram of the growth of the fetal alveolar ridge between 14 and 32 weeks' gestation. This will aid the detection of primary cleft palate during routine prenatal sonography.     

Early fetal megacystis between 11 and 15 weeks of gestation.

OBJECTIVE: The purpose of this study was to evaluate the prognostic criteria of early fetal megacystis. DESIGN: A prospective, transvaginal ultrasound, cross-sectional study at 11-15 weeks of gestation at a tertiary referral fetal medicine unit. SUBJECTS AND METHODS: Sixteen pregnancies out of a total of 5240 were identified with early fetal megacystis. Fetal biometry, morphology, amniotic fluid, bladder size and volume were also evaluated. The karyotype was available in 15 cases. Vesicocentesis was performed in six fetuses and three had concomitant cystoscopies. RESULTS: In six fetuses, the megacystis was isolated. In the remaining ten, we detected associated hygroma (n = 5), nuchal translucency (n = 3), omphalocele (n = 1), mild pyelectasis (n = 1) and bilateral talipes (n = 1). In three cases the fetuses demonstrated renal hyperechogenicity with cysts, and in two cases oligohydramnios was found; four cases (25%) had chromosomal abnormalities; 47, XY + 13 (two cases), 47, XY + 18 and 47, XY + 21. Only one fetus from this study survived. In the remaining 13 cases, termination was proposed after counselling of the patients on the poor prognosis. The mean gestational age at termination was 15.5 +/- 2.4 weeks (range 12-20). Three fetal transabdominal cystoscopies did not allow us to view the valves; one urethral atresia was suspected, and confirmed postnatally. CONCLUSIONS: We found a high rate of associated malformations, especially intestinal malformations. The systematic evaluation of the intestinal enzymes in the amniotic fluid and urine samples might be an important aid in the diagnosis of multiple malformations, such as cloacal dysgenesis.     

羊水量异常的超声诊断与胎儿畸形的关系

目的 探讨羊水量异常与胎儿畸形的关系.方法 回顾分析2004年3月至2006年11月在本院进行二维及三维超声检查34 900例20周以上的胎儿,其检出羊水量异常160例,并研究分析羊水量多少与胎儿畸形的关系.结果 160例羊水量异常中,羊水过多100例,羊水过少60例,二者畸形的发生率分别为37%、31.6%.结论 超声是诊断羊水量异常的首选方法,而且还能发现胎儿畸形,进一步证明羊水量异常与胎儿畸形的发生密切相关.     

A nomogram of fetal lung volumes estimated by 3-dimensional ultrasonography using the rotational technique (virtual organ computer-aided analysis).

OBJECTIVE: The purpose of this study was to build a nomogram of normal fetal lung volumes throughout gestational age estimated by 3-dimensional ultrasonography using the rotational technique (Virtual Organ Computer-Aided Analysis [VOCAL]; GE Healthcare, Kretztechnik, Zipf, Austria). METHODS: Fetal lung volume was assessed in 146 healthy fetuses by 3-dimensional ultrasonography using the technique of rotation of the multiplanar imaging (VOCAL). Inclusion criteria were healthy women with singleton normal pregnancies, normal fetal morphologic ultrasonographic findings, reliable dating established by dates and by ultrasonographic measurement of the crown-lump length in the first trimester, and gestational age from 20 to 37 weeks. Exclusion criteria were discordance between clinical and ultrasonographic dating, patients lost to follow-up, and birth weight disorders. Each patient was scanned once during pregnancy. RESULTS: The right, left, and total mean pulmonary volumes ranged, respectively, from 5.37, 4.66, and 9.95 cm3 at 20 weeks to 46.06, 37.34, and 84.35 cm3 at 37 weeks. The logistic transformation analysis yielded the following formulas: right lung volume = exp(4.07/[1 + exp(21.90 - gestational age/5.44)]); left lung volume = exp(3.82/(1 + exp[22.03 - gestational age/5.17)]); and, total lung volume = exp(4.72/[1 + exp(20.30 - gestational age/6.05)]). CONCLUSIONS: A new nomogram of fetal lung (right, left, and total) volumes throughout gestational age using the rotational technique (VOCAL) is described, and reference values have been generated.     

Fetal lung volume: three-dimensional ultrasonography compared with magnetic resonance imaging.

OBJECTIVES: An accurate and reliable method for measuring fetal lung volumes would be helpful in predicting the outcome in cases with suspected impaired lung growth. Recent studies show that it is possible to obtain fetal lung volume estimations with magnetic resonance imaging (MRI) and three-dimensional (3D) ultrasonography. The purpose of this study was to assess the agreement of lung volumes measured with 3D ultrasonography and MRI in uncomplicated pregnancies. METHODS: This was a prospective study in which MRI and 3D ultrasonography examinations were conducted on the same day to measure the fetal lung volumes of 10 women with uncomplicated pregnancies. Intraclass correlation was used to evaluate the agreement between fetal lung volume measurements obtained by MRI and 3D ultrasonography. A proportionate Bland-Altman plot was constructed. RESULTS: The intraclass correlation coefficient between MRI and 3D ultrasonography measurements for the right lung was 0.92 (95% CI 0.71-0.98) and for the left lung was 0.95 (95% CI 0.82-0.99). The proportionate limits of agreement between the methods were for the right lung -32.57% to 20.03% and for the left lung -21.26% to 17.13%. CONCLUSIONS: There is good agreement between lung volumes measured by MRI and those measured by 3D ultrasonography.     

水通道蛋白8在人胎膜中的表达

目的了解水通道蛋白8(AQP8)在人胎膜中的表达。方法收集羊水量正常、足月、选择剖宫产的胎膜组织样本10例,运用RT-PCR法及免疫组化SABC法检测人胎膜组织中水通道蛋白8(AQP8)的表达。结果 AQP8在人胎膜的羊膜上皮细胞有表达。结论 AQP8可能参与人羊水循环及其调节。